EUVIMEDEUVIMED entdecken
Open Access

Body composition following gender affirming hormone therapy in transgender individuals

Bharathi Kolla, Pramila Kalra

The Indian Journal of Medical Research · 2025

DOI: 10.25259/ijmr_560_2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Indian Journal of Medical Research, 2025. Verfasst von Bharathi Kolla und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Transgender Persons, Body Composition, Fibronectins, Transsexualism. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & objectives Gender-affirming hormone therapy may alter body composition and muscle strength, which may impact participation in sports and other activities. These changes are important to decide whether transgender should have separate categories of competition.

Methods

We conducted this prospective study, to assess the body composition using bioelectrical impedance analysis muscle strength and serum irisin levels at baseline and at 12 months following gender affirming hormone therapy in transgender individuals. The comparisons were done in both cis mode and trans mode.

Results

A total of 32 transfemales and 22 transmales were included in the study. Among transwomen, there was an increase in total subcutaneous fat (9.2%) and visceral fat (11.3 %) ( P < 0.001 in both cis and trans mode comparison) and a decrease in muscle mass (7.7%) ( P = 0.033 and P < 0.001 in cis and trans mode, respectively) and muscle strength at all sites ( P < 0.001). Among transmen, there was a decrease in total subcutaneous fat (5.9%) ( P < 0.001 for both cis and trans mode comparison) and an increase in muscle mass (7.2 %) ( P < 0.001 for trans mode only) and muscle strength except shoulder abduction on right side ( P < 0.001). No significant changes were observed in irisin levels following hormonal therapy. Interpretation & conclusions Gender affirming hormonal therapy leads to body fat redistribution after twelve months of hormone therapy with significant alterations in muscle mass and strength among both transmen and transwomen. Irisin, an adipomyokine produced through muscle contraction, did not correlate with muscle mass or fat mass on follow up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transgender PersonsBody CompositionFibronectinsTranssexualismHumansFemaleMaleAdultMuscle StrengthTestosteroneElectric ImpedanceHormone Replacement TherapySubcutaneous FatIntra-Abdominal FatProspective Studies

Stichwörter der Autor:innen

Body compositiongender-affirming hormone therapymuscle massmuscle strengthserum irisin

Substanzen

FibronectinsFNDC5 protein, humanTestosterone

Zitieren

APA

Kolla, B., & Kalra, P. (2025). Body composition following gender affirming hormone therapy in transgender individuals. The Indian Journal of Medical Research. https://doi.org/10.25259/ijmr_560_2025

Vancouver

Kolla B, Kalra P. Body composition following gender affirming hormone therapy in transgender individuals. The Indian Journal of Medical Research. 2025. doi:10.25259/ijmr_560_2025

BibTeX
@article{Kolla2025,
  author = {Kolla, Bharathi and Kalra, Pramila},
  title = {Body composition following gender affirming hormone therapy in transgender individuals},
  journal = {The Indian Journal of Medical Research},
  year = {2025},
  doi = {10.25259/ijmr_560_2025}
}
Kostenlos starten →